References of "Rousseau, Anne-Françoise"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailPhage therapy against antimicrobial resistance, design of the first clinical study Phagoburn.
Jault, Patrick; Gabard, Jérôme; Leclerc, Thomas et al

in Critical Care (2016), 20(Suppl 2), 109

Detailed reference viewed: 35 (0 ULg)
Peer Reviewed
See detailNutrition du brûlé grave.
ROUSSEAU, Anne-Françoise ULg; Cynober, Luc; Berger, Mette M.

in Quilliot, Didier; Thibault, Ronan; Bachmann, Patrick (Eds.) et al Traité de nutrition clinique. (2016)

Detailed reference viewed: 16 (3 ULg)
Peer Reviewed
See detailLa réanimation des brûlés en Belgique
ROUSSEAU, Anne-Françoise ULg

in Anesthésie, analgésie, réanimation, SAMU. Notre histoire, de 1945 aux années 2000. Tome III: Réanimation (2016)

Detailed reference viewed: 19 (5 ULg)
Peer Reviewed
See detailBrûlures domestiques enfants et adultes : les gestes qui sauvent.
ROUSSEAU, Anne-Françoise ULg

Conference (2015, December 08)

Detailed reference viewed: 15 (1 ULg)
Full Text
Peer Reviewed
See detailVitamin D status after a high dose of cholecalciferol in healthy and burn subjects
ROUSSEAU, Anne-Françoise ULg; DAMAS, Pierre ULg; LEDOUX, Didier ULg et al

in Burns : Journal of the International Society for Burn Injuries (2015), 41(5), 1028-1034

Background: Burn patients are at risk of vitamin D (VD) deficiency and may benefit from its pleiotropic effects as soon as acute phase. Aim of this observational study was to assess effects of a ... [more ▼]

Background: Burn patients are at risk of vitamin D (VD) deficiency and may benefit from its pleiotropic effects as soon as acute phase. Aim of this observational study was to assess effects of a cholecalciferol (VD3) bolus on VD status in adult burn patients (Group B, GB) after admission, compared to healthy subjects (Group H, GH). Methods: Both groups received an oral dose of 100,000 IU VD3. Blood samples were collected before (D0) and 7 days (D7) after bolus to measure 250H-D, 1,25(OH)2-D, parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23). Albumin (ALB) and VD binding protein (DBP) were measured and used to calculate free 25OH-D level. Data were expressed as median (min–max) or proportions. Results: A total of 49 subjects were included: 29 in GH and 20 in GB. At D0, prevalence of VD deficiency was higher in GB: 25OH-D was 21.5 (10.1–46.3) ng/ml in GH vs 11 (1.8–31.4) ng/ml in GB. DBP and ALB were lower in GB. At D7, DBP was stable in both groups while ALB decreased in GB. 25OH-D increased by 66.6 (13.5–260.3)% in GH. In GB, changes in 25OH-D extended from 36.7% to 333.3% with a median increase of 33.1%. Similar changes were observed in each group for free 25OH-D. High FGF23 levels were observed in GB. Conclusions: This study highlighted the differences in VD status and in response to a high dose VD3 in burn patients when compared to healthy patients. Pitfalls in VD status assessment are numerous during acute burn care: 25OH-D measurement needs cautious interpretation and interest of free 25OH-D is still questionable. They should not prevent burn patients to receive VD supplements during acute care. Higher doses than general recommendations should probably be considered. [less ▲]

Detailed reference viewed: 32 (15 ULg)
See detailBesoins lipidiques du patient brûlé.
ROUSSEAU, Anne-Françoise ULg

Conference (2015, June)

Detailed reference viewed: 13 (0 ULg)
Full Text
Peer Reviewed
See detailSerum markers of sepsis in burn patients: it takes more to convince!
ROUSSEAU, Anne-Françoise ULg; LAYIOS, Nathalie ULg

in Critical Care Medicine (2015), 43(3), 100-1

Detailed reference viewed: 19 (2 ULg)
Full Text
Peer Reviewed
See detaileffects of cholecaciferol supplementation and optimized calcium intakes on vitamin D status, muscle strength and bone health: a one-year pilot randomized controlled trial in adults with severe burns
ROUSSEAU, Anne-Françoise ULg; FOIDART-DESSALLE, Marguerite ULg; LEDOUX, Didier ULg et al

in Burns : Journal of the International Society for Burn Injuries (2015), 41(2), 317-325

Objective: Burn patients are at risk of hypovitaminosis D and osteopenia or sarcopenia. Vitamin D pleiotropic effects may influence bone and muscle health. The aim of this pilot study was to assess ... [more ▼]

Objective: Burn patients are at risk of hypovitaminosis D and osteopenia or sarcopenia. Vitamin D pleiotropic effects may influence bone and muscle health. The aim of this pilot study was to assess effects of a cholecalciferol (VD3) supplementation and an optimized calcium (Ca) regimen on vitamin D (VD) status, bone and muscle health during sequelar stage of burn injury. Design: Monocentric randomized controlled trial. Methods: Fifteen adults with thermal burns dating from 2 to 5 years were randomized into two groups. For 12 months, they either received a quarterly IM injection of 200,000 IU VD3 and daily oral Ca (Group D) or placebo (Group P). VD status and bone remodeling markers were assessed every 3 months. Knee muscle strength and bone mineral density were, respectively, assessed using isokinetic dynamometry and dual X-ray absorptiometry at initiation (M0) and completion (M12) of the protocol. Results: Of all the patients, 66% presented with VD deficiency and 53% (with 3 men <40 y) were considered osteopenic at inclusion. After one year, calcidiol levels significantly increased in Group D to reach 40 (37–61) ng/ml. No significant change in bone health was observed in both groups while Group D significantly improved quadriceps strength when tested at high velocity. Conclusions: This VD3 supplementation was safe and efficient to correct hypovitaminosis D in burn adults. When combined with optimized Ca intakes, it demonstrated positive effects on muscle health but not on bone health. A high prevalence of hypovitaminosis D and osteopenia in these patients, as well as their wide range of muscle performances, seem to be worrying when considering rehabilitation and quality of life. [less ▲]

Detailed reference viewed: 45 (14 ULg)
Full Text
Peer Reviewed
See detailVitamin D status in critically ill patients: back to basics!
ROUSSEAU, Anne-Françoise ULg; CAVALIER, Etienne ULg

in Critical Care (2014), 18(6), 611

Detailed reference viewed: 16 (2 ULg)
See detailControverses : cooling or not cooling ?
ROUSSEAU, Anne-Françoise ULg; TRIPPAERTS, Marc ULg

Conference (2014, May)

Detailed reference viewed: 12 (0 ULg)
Full Text
Peer Reviewed
See detailEffect of gamma-hydroxybutyrate on keratinocytes proliferation: a preliminary prospective controlled study in severe burn patients.
ROUSSEAU, Anne-Françoise ULg; BARGUES, Laurent; LE BEVER, Hervé et al

in International Journal of Critical Illness and Injury Science (2014), 4(2), 108-113

Detailed reference viewed: 30 (13 ULg)
Full Text
Peer Reviewed
See detailTowards targeted early burn care: lessons from a European survey.
ROUSSEAU, Anne-Françoise ULg; MASSION, Paul ULg; LAUNGANI, Alexis ULg et al

in Journal of Burn Care & Research (2014), 35

Detailed reference viewed: 13 (3 ULg)
Full Text
Peer Reviewed
See detailEffect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study.
PAQUET, Philippe ULg; JENNES, Serge; ROUSSEAU, Anne-Françoise ULg et al

in Burns : Journal of the International Society for Burn Injuries (2014)

Detailed reference viewed: 33 (4 ULg)
See detailBrûlure et infection
ROUSSEAU, Anne-Françoise ULg

Scientific conference (2013, December 05)

Detailed reference viewed: 30 (5 ULg)